GEFAPIXANT IS THE FIRST TREATMENT TO SHOW EFFICACY IN PHASE 3 CLINICAL TRIALS FOR REFRACTORY CHRONIC COUGH OR UNEXPLAINED CHRONIC COUGH.
Chronic cough is a daily cough that lasts greater than eight weeks. In Canada, up to 16% of adults over the age of 45 years have a chronic cough.
Vision
To improve quality of life for patients living with chronic cough.
Mission
We aim to achieve our vision by providing patients with the best clinical care available and by researching chronic cough to improve our understanding of why it happens, and how it can be treated.
About our Clinic
Our clinical team bring years of experience to bear on the greatest challenge of our time. We’re results driven, with a proven record of previous successes.
About our Research
The Cardio-Respiratory Research Laboratory aims to provide excellence in research and innovation in the areas of basic and applied health science that impact positively on the treatment of cough.
Contact us if you are interested in participating in our research studies.